COMBINED THERAPY WITH LOW DOSE HEPATITIS B IMMUNOGLOBULIN AND LAMIVUDINE IN PATIENTS TRANSPLANTED FOR HBV END STAGE LIVER DISEASE: STILL COST-EFFECTIVE? / Giusto, Michela; V., Di Gregorio; Giannelli, Valerio; Lucidi, Cristina; Rossi, Massimo; Mennini, Gianluca; Melandro, Fabio; GINANNI CORRADINI, Stefano; Attili, Adolfo Francesco; Merli, Manuela. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - STAMPA. - 44:(2012), pp. S103-S103. (Intervento presentato al convegno 18th National Congress of Digestive Diseases, Italian Federation of Societies of Digestive Diseases tenutosi a Naples, ITALY nel 28–31 March 2012) [10.1016/s1590-8658(12)60281-3].
COMBINED THERAPY WITH LOW DOSE HEPATITIS B IMMUNOGLOBULIN AND LAMIVUDINE IN PATIENTS TRANSPLANTED FOR HBV END STAGE LIVER DISEASE: STILL COST-EFFECTIVE?
GIUSTO, MICHELA;GIANNELLI, VALERIO;LUCIDI, CRISTINA;ROSSI, MASSIMO;MENNINI, Gianluca;MELANDRO, FABIO;GINANNI CORRADINI, Stefano;ATTILI, Adolfo Francesco;MERLI, Manuela
2012
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.